Related Experiment Video
Updated: Apr 22, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts
Hairong Xu1, Yanhong Zhou2, Kathleen A Coughlan3
1Section of Molecular Medicine, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; School of Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China.
Abstract:
Emerging evidence suggests that activation of adenosine monophosphate-activated protein kinase (AMPK), an energy gauge and redox sensor, controls the cell cycle and protects against DNA damage. However, the molecular mechanisms by which AMPKα isoform regulates DNA damage remain largely unknown. The aim of this study was to determine if AMPKα deletion contributes to cellular hyperproliferation by reducing p21(WAF1/Cip1) (p21) expression thereby leading to accumulated DNA damage. The markers for DNA damage, cell cycle proteins, and apoptosis were monitored in cultured mouse embryonic fibroblasts (MEFs) isolated from wild type (WT, C57BL/6J), AMPKα1, or AMPKα2 homozygous deficient (AMPKα1(-/-), AMPKα2(-/-)) mice by Western blot, flow cytometry, and cellular immunofluorescence staining. Deletion of AMPKα1, the predominant AMPKα isoform, but not AMPKα2 in immortalized MEFs led to spontaneous DNA double-strand breaks (DSB) which corresponded to repair protein p53-binding protein 1 (53BP1) foci formation and subsequent apoptosis. Furthermore, AMPKα1 localizes to chromatin and AMPKα1 deletion down-regulates cyclin-dependent kinase inhibitor, p21, an important protein that plays a role in decreasing the incidence of spontaneous DSB via inhibition of cell proliferation. In addition, AMPKα1 null cells exhibited enhanced cell proliferation. Finally, p21 overexpression partially blocked the cellular hyperproliferation of AMPKα1-deleted MEFs via the inhibition of cyclin-dependent kinase 2 (CDK2). Taken together, our results suggest that AMPKα1 plays a fundamental role in controlling the cell cycle thereby affecting DNA damage and cellular apoptosis.
Insights
Adenosine monophosphate-activated protein kinase alpha 1 (AMPKα1) deletion causes DNA damage and apoptosis by reducing p21 expression. AMPKα1 controls cell cycle, impacting DNA damage and apoptosis.
Area of Science:
- Cellular biology
- Molecular mechanisms of DNA damage
- Protein kinase signaling
Background:
- Adenosine monophosphate-activated protein kinase (AMPK) is an energy sensor involved in cell cycle control and DNA damage protection.
- The specific role of AMPKα isoforms in regulating DNA damage is not well understood.
Purpose of the Study:
- To investigate whether AMPKα deletion contributes to cellular hyperproliferation by reducing p21(WAF1/Cip1) (p21) expression, leading to DNA damage accumulation.
- To elucidate the molecular mechanisms by which AMPKα isoforms regulate DNA damage.
Main Methods:
- Western blot, flow cytometry, and immunofluorescence staining were used to analyze DNA damage markers, cell cycle proteins, and apoptosis.
- Primary mouse embryonic fibroblasts (MEFs) from wild-type, AMPKα1(-/-), and AMPKα2(-/-) mice were utilized.
Main Results:
- AMPKα1 deletion, but not AMPKα2, resulted in spontaneous DNA double-strand breaks (DSB) and apoptosis.
- AMPKα1 localizes to chromatin and its deletion down-regulates p21, a key inhibitor of DSB.
- AMPKα1-null cells showed increased proliferation, which was partially rescued by p21 overexpression via CDK2 inhibition.
Conclusions:
- AMPKα1 plays a critical role in cell cycle regulation, influencing DNA damage and apoptosis.
- Down-regulation of p21 by AMPKα1 deletion contributes to cellular hyperproliferation and DNA damage.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

